Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Spring Home & Garden Show
Home & Realty
Outdoor Guide
Women
Spring on the Road
Spring Wellness
Premier Home Stylle Tour 2024
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
2024 Readersâ Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by iRadimed Corporation
IRADIMED CORPORATION Announces Second Quarter of 2024 Financial Results and the Declaration of its Regular Quarterly Cash Dividend of $0.15 Per Share
August 01, 2024
From
iRadimed Corporation
Via
GlobeNewswire
Tickers
IRMD
IRADIMED CORPORATION to Hold 2024 Second Quarter Financial Results Conference Call on August 1st
July 25, 2024
From
iRadimed Corporation
Via
GlobeNewswire
Tickers
IRMD
IRADIMED CORPORATION Announces Uplisting to The Nasdaq Global Market
June 07, 2024
From
iRadimed Corporation
Via
GlobeNewswire
Tickers
IRMD
IRADIMED CORPORATION Announces First Quarter of 2024 Financial Results and the Declaration of its Regular Quarterly Cash Dividend of $0.15 Per Share
May 02, 2024
From
iRadimed Corporation
Via
GlobeNewswire
Tickers
IRMD
IRADIMED CORPORATION to Hold 2024 First Quarter Financial Results Conference Call on May 2nd
April 25, 2024
From
iRadimed Corporation
Via
GlobeNewswire
Tickers
IRMD
IRADIMED CORPORATION To Participate at the 36th Annual Roth Conference
March 13, 2024
From
iRadimed Corporation
Via
GlobeNewswire
Tickers
IRMD
IRADIMED CORPORATION Announces Fourth Quarter of 2023 and Full Year of 2023 Financial Results
February 08, 2024
From
iRadimed Corporation
Via
GlobeNewswire
Tickers
IRMD
IRADIMED CORPORATION to Hold 2023 Fourth Quarter Financial Results Conference Call on February 8th.
February 01, 2024
From
iRadimed Corporation
Via
GlobeNewswire
Tickers
IRMD
IRADIMED CORPORATION Reports Unaudited Fourth Quarter and 2023 Revenue
January 09, 2024
From
iRadimed Corporation
Via
GlobeNewswire
Tickers
IRMD
IRADIMED CORPORATION To Present at the 42nd Annual J.P. Morgan Healthcare Conference
January 02, 2024
From
iRadimed Corporation
Via
GlobeNewswire
Tickers
IRMD
IRADIMED CORPORATION Announces Establishment of a Quarterly Dividend of $0.15 per share and a Special Cash Dividend of $0.48 per share
December 12, 2023
From
iRadimed Corporation
Via
GlobeNewswire
Tickers
IRMD
IRADIMED CORPORATION Named a 2024 Most Successful Small-Cap Company in America by Forbes
November 30, 2023
From
iRadimed Corporation
Via
GlobeNewswire
Tickers
IRMD
IRADIMED CORPORATION Announces Third Quarter 2023 Financial Results
November 03, 2023
From
iRadimed Corporation
Via
GlobeNewswire
Tickers
IRMD
IRADIMED CORPORATION to Hold 2023 Third Quarter Financial Results Conference Call on November 3rd
October 26, 2023
From
iRadimed Corporation
Via
GlobeNewswire
Tickers
IRMD
IRADIMED CORPORATION to Participate at Upcoming Investor Conferences
September 06, 2023
From
iRadimed Corporation
Via
GlobeNewswire
Tickers
IRMD
IRADIMED CORPORATION Announces Second Quarter 2023 Financial Results
August 03, 2023
From
iRadimed Corporation
Via
GlobeNewswire
Tickers
IRMD
IRADIMED CORPORATION to Hold 2023 Second Quarter Financial Results Conference Call on August 3rd
July 27, 2023
From
iRadimed Corporation
Via
GlobeNewswire
Tickers
IRMD
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.